Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLS
Authors not listed
Medstar Health Research Institute · 2006
Abstract
The primary objective of this clinical trial is to assess the efficacy of rosiglitazone on bare metal stent (BMS) in-stent restenosis measured as late lumen loss in patients with metabolic syndrome.
The secondary parameter for evaluation of efficacy is binary restenosis.
The tertiary objective will be to assess the effect of rosiglitazone on major cardiac events (MACE; death, MI, CABG, and target vessel revascularization). The occurrence of in-stent restenosis for patients with metabolic syndrome who receive a DES in a non-target lesion will be assessed angiographically at 9 months.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-13 MST
Cite this
APA
Anonymous. (2006). Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLS. <em>Medstar Health Research Institute</em>. https://clinicaltrials.gov/study/NCT00465296
Vancouver
Anonymous. Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLS. Medstar Health Research Institute. 2006.
BibTeX
@misc{anon2006PparGa,
title = {Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLS},
author = {Anonymous},
journal = {Medstar Health Research Institute},
year = {2006},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neuroscience Applied 2022
Open access · CC-BY
Telomere length attrition correlated with age in male bipolar patients with no effect of long-term lithium-treatment
Fundación para la Investigación del Hospital Clínico de Valencia 2026
Open access · US-GOV
Phase IV, Open-label, Randomized Clinical Trial on the Effect of Intravenous Iron on Quality of Life in Elderly Patients With Acute Coronary Syndrome
US Department of Veterans Affairs 2004
Open access · US-GOV
Efficacy of Digital Noise Reduction Strategies: A Hearing Aid Trial
Experimental Cell Research 2002
Citation only
Telomere Biology and Cellular Aging in Nonhuman Primate Cells
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 2025
Open access · US-GOV
A Phase III, Randomized, Double-blinded Study of the Efficacy and Safety of LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome (the LESS-AD Trial).
Progress in molecular biology and translational science 2014
Citation only